The effects of sunlight on the skin

Drug Discovery Today: Disease Mechanisms

Volumn 5, Issue 2, 2008, Pages

  Halliday, Gary M ^a   Norval, Mary ^b   Byrne, Scott N ^a   Huang, Xiao X ^a   Wolf, Peter ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; DNA; IMIQUIMOD; LIPID; PORPHYRIN DERIVATIVE; PSORALEN; VITAMIN D;

ATOPIC DERMATITIS; CANCER CONTROL; DISEASE MODEL; DNA DAMAGE; DRUG MECHANISM; GRAFT VERSUS HOST REACTION; HEALTH HAZARD; HUMAN; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; NONHUMAN; OXIDATIVE STRESS; PHOTOTHERAPY; PSORIASIS; RADIATION ABSORPTION; RASH; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; SKIN DISEASE; SUNLIGHT; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; URTICARIA PIGMENTOSA; VITILIGO;

EID: 65049090546     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2008.04.005     Document Type: Review

References (64)

1. Halliday G.M. Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat. Res. 571 (2005) 107-120
2. Brash D.E., et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 10124-10128
3. Darr D., and Fridovich I. Free radicals in cutaneous biology. J. Invest. Dermatol. 102 (1994) 671-675
4. Stary A., and Sarasin A. Ultraviolet A- and singlet oxygen-induced mutation spectra. Methods Enzymol. 319 (2000) 153-165
5. Kappes U.P., et al. Short- and long-wave UV light (UVB and UVA) induce similar mutations in human skin cells. J. Invest. Dermatol. 126 (2006) 667-675
6. Drobetsky E.A., et al. A role for ultraviolet A in solar mutagenesis. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 2350-2354
7. Persson A., et al. The mutagenic effect of ultraviolet-A1 on human skin demonstrated by sequencing the p53 gene in single keratinocytes. Photodermatol. Photoimmunol. Photomed. 18 (2002) 287-293
8. Besaratinia A., et al. G-to-T transversions and small tandem base deletions are the hallmark of mutations induced by ultraviolet A radiation in mammalian cells. Biochemistry 43 (2004) 8169-8177
9. Ouhtit A., et al. Loss of Fas-ligand expression in mouse keratinocytes during UV carcinogenesis. Am. J. Pathol. 157 (2000) 1975-1981
10. Agar N.S., et al. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 4954-4959
11. De Gruijl F.R., et al. Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice. Cancer Res. 53 (1993) 53-60
12. Ravanat J.L., et al. Direct and indirect effects of UV radiation on DNA and its components. J. Photochem. Photobiol. B 63 (2001) 88-102
13. Pattison D.I., and Davies M.J. Actions of ultraviolet light on cellular structures. In: Bignold L.P. (Ed). Cancer: Cell structures, carcinogens and genomic instability (2006), Birkhauser Verlag AG, Basel 131-157
14. Pryor W.A., and Squadrito G.L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268 5 Pt 1 (1995) L699-722
15. Salgo M.G., et al. Peroxynitrite causes DNA nicks in plasmid pBR322. Biochem. Biophys. Res. Commun. 210 (1995) 1025-1030
16. Zingarelli B., et al. Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J. Immunol. 156 (1996) 350-358
17. Jurkiewicz B.A., and Buettner G.R. EPR detection of free radicals in UV-irradiated skin: mouse versus human. Photochem. Photobiol. 64 (1996) 918-922
18. Bissett D.L., et al. Chronic ultraviolet radiation-induced increase in skin iron and the photoprotective effect of topically applied iron chelators. Photochem. Photobiol. 54 (1991) 215-223
19. Wolf P., et al. Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. Am. J. Pathol. 169 (2006) 795-805
20. Ullrich S.E. Sunlight and skin cancer: lessons from the immune system. Mol. Carcinog. 46 (2007) 629-633
21. Russo P.A.J., and Halliday G.M. Inhibition of nitric oxide and reactive oxygen species production improves the ability of a sunscreen to protect from sunburn, immunosuppression and photocarcinogenesis. Br. J. Dermatol. 155 (2006) 408-415
22. Fritsche E., et al. Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 8851-8856
23. Oh G.S., et al. 3-Hydroxyanthranilic acid, one of metabolites of tryptophan via indoleamine 2,3-dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression. Biochem. Biophys. Res. Commun. 320 (2004) 1156-1162
24. Serbecic N., and Beutelspacher S.C. Indoleamine 2,3-dioxygenase protects corneal endothelial cells from UV mediated damage. Exp. Eye Res. 82 (2006) 416-426
25. Kripke M.L. Immunologic unresponsiveness induced by UV radiation. Immunological. Rev. 80 (1984) 87-102
26. Vink A.A., et al. Cellular target of UVB-induced DNA damage resulting in local suppression of contact hypersensitivity. J. Photochem. Photobiol. B - Biol. 44 (1998) 107-111
27. Norval M., and El-Ghorr A.A. Studies to determine the immunomodulating effects of cis-urocanic acid. Methods 28 (2002) 63-70
28. Beissert S., and Loser K. Molecular and cellular mechanisms of photocarcinogenesis. Photochem. Photobiol. 84 (2008) 29-34
29. Moodycliffe A.M., et al. Immune suppression and skin cancer development: regulation by NKT cells. Nat. Immunol. 1 (2000) 521-525
30. Kuchel J.M., et al. Nitric oxide appears to be a mediator of solar-simulated ultraviolet radiation-induced immunosuppression in humans. J. Invest. Dermatol. 121 (2003) 587-593
31. Walterscheid J.P., et al. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J. Exp. Med. 195 (2002) 171-179
32. Matsumura Y., et al. A role for inflammatory mediators in the induction of immunoregulatory B cells. J. Immunol. 177 (2006) 4810-4817
33. Kripke M.L., et al. Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 7516-7520
34. Jans J., et al. Powerful skin cancer protection by a CPD-photolyase transgene. Curr. Biol. 15 (2005) 105-115
35. Loser K., et al. IL-10 controls ultraviolet-induced carcinogenesis in mice. J. Immunol. 179 (2007) 365-371
36. Grimbaldeston M.A., et al. Mast cells in photodamaged skin: what is their role in skin cancer?. Photochem. Photobiol. Sci. 5 (2006) 177-183
37. Kelly D.A., et al. Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity. J. Exp. Med. 191 (2000) 561-566
38. Norval M., et al. UV-induced changes in the immune response to microbial infections in human subjects and animal models. J. Epidemiol. 9 6 Suppl. (1999) S84-S92
39. Norval M. The effect of ultraviolet radiation on human viral infections. Photochem. Photobiol. 82 (2006) 1495-1504
40. Sleijffers A., et al. Influence of ultraviolet B exposure on immune responses following hepatitis B vaccination in human volunteers. J. Invest. Dermatol. 117 (2001) 1144-1150
41. Sleijffers A., et al. Cytokine polymorphisms play a role in susceptibility to ultraviolet B-induced modulation of immune responses after hepatitis B vaccination. J. Immunol. 170 (2003) 3423-3428
42. Kricker A., and Armstrong B. Does sunlight have a beneficial influence on certain cancers?. Prog. Biophys. Mol. Biol. 92 (2006) 132-139
43. Diamond T.H., et al. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med. J. Austr. 182 (2005) 281-285
44. Gupta R., et al. Photoprotection by 1,2,5 dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in nitric oxide products. J. Invest. Dermatol. 127 (2007) 707-715
45. Hanneman K.K., et al. Effect of topical vitamin D analogue on in vivo contact sensitization. Arch. Dermatol. 142 (2006) 1332-1334
46. Morison W.L., and Hönigsmann H. Psoralen photochemotherapy. In: Lim H.W., et al. (Ed). Photodermatology (2007), Informa Healthcare 347-357
47. Legat F.J., et al. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA. J. Am. Acad. Dermatol. 51 (2004) 746-754
48. Wackernagel A., et al. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides. Br. J. Dermatol. 154 (2006) 519-523
49. Hofer A., et al. Paired comparison of bathwater versus oral delivery of 8-methoxypsoralen in psoralen plus ultraviolet: A therapy for chronic palmoplantar psoriasis. Photodermatol. Photoimmunol. Photomed. 22 (2006) 1-5
50. Knobler R., and Jantschitsch C. Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma. Transfus Apher. Sci. 28 (2003) 81-89
51. Greinix H.T., et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica 91 (2006) 405-408
52. Knobler R.M., et al. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis. J. Am. Acad. Dermatol. 54 (2006) 793-799
53. Walterscheid J.P., et al. Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 17420-17425
54. Wolf P., et al. Mast cell-derived 5-HT is required for the induction of PUVA-induced systemic immune suppression but not local inflammation. J. Invest. Dermatol. 127 Suppl. 2 (2007) S41
55. Schwarz A., et al. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J. Immunol. 172 (2004) 1036-1043
56. Loser K., et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 12 (2006) 1372-1379
57. Wolf P., et al. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?. J. Am. Acad. Dermatol. 28 (1993) 17-21
58. Morton C., et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Arch. Dermatol. 142 (2006) 729-735
59. Rhodes L.E., et al. Photodynamic therapy using topical methyl aminolevulinate vs. surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch. Dermatol. 140 (2004) 17-23
60. Stott B., and Korbelik M. Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy. Cancer Immunol. Immunother. 56 (2007) 649-658
61. Horn M., and Wolf P. Topical methyl aminolevulinate photodynamic therapy for the treatment of folliculitis. Photodermatol. Photoimmunol. Photomed. 23 (2007) 145-147
62. Poon T.S.C., et al. Prevention of immunosuppression by sunscreens in humans is unrelated to protection from erythema and dependent on protection from ultraviolet A in the face of constant ultraviolet B protection. J. Invest. Dermatol. 121 (2003) 184-190
63. Wang Z.Y., et al. Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols. Carcinogenesis 12 (1991) 1527-1530
64. Legat F.J., et al. Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis. Arch. Dermatol. 143 (2007) 1016-1022